Ixazomib-Dexamethasone vs Physician's Choice in Relapsed or Refractory AL Amyloidosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Leukemia
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Randomized Phase 3 Study of Ixazomib-Dexamethasone Versus Physician's Choice in Relapsed or Refractory AL Amyloidosis
Leukemia 2021 Jun 24;[EPub Ahead of Print], A Dispenzieri, E Kastritis, AD Wechalekar, SO Schönland, K Kim, V Sanchorawala, HJ Landau, F Kwok, K Suzuki, RL Comenzo, D Berg, G Liu, A Kumar, DV Faller, G MerliniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.